Whereas the median papilloma-free survival was 10.7 weeks in oil-treated K14CRE-ERT2-STIL+/- control mice, tamoxifen-treated animals developed papillomas with a much longer latency (16.7 weeks; p<0.001, log-rank test) (Fig 7A). This evidence concerns the gene MAPK3 and papilloma.